Systemic myostatin inhibition via liver-targeted gene transfer in normal and dystrophic mice

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Morine, Kevin J ^a   Bish, Lawrence T ^a   Pendrak, Klara ^a   Sleeper, Meg M ^b   Barton, Elisabeth R ^c   Sweeney, H Lee ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA SCHOOL OF VETERINARY MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOSIN HEAVY CHAIN; MYOSTATIN; MUTANT PROTEIN;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; GENE; GENE TRANSFER; HEART HYPERTROPHY; LIVER; MDX GENE; MOUSE; NONHUMAN; SOLEUS MUSCLE; ANIMAL; ANIMAL MUSCULAR DYSTROPHY; C57BL MOUSE; GENE VECTOR; GENETICS; HUMAN; METABOLISM; MUTATION; NEWBORN; PATHOLOGY; PATHOPHYSIOLOGY; SKELETAL MUSCLE; TIME; TRANSGENIC MOUSE; WESTERN BLOTTING; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ADENO-ASSOCIATED VIRUS; MUS;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; DEPENDOVIRUS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LIVER; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MICE, TRANSGENIC; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; MUSCULAR DYSTROPHY, DUCHENNE; MUTANT PROTEINS; MUTATION; MYOSTATIN; TIME FACTORS;

EID: 77949453616     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009176     Document Type: Article

References (62)

1. Lee SJ (2007) Sprinting without myostatin: a genetic determinant of athletic prowess. Trends Genet 23: 475-477.
2. Durieux AC, Amirouche A, Banzet S, Koulmann N, Bonnefoy R, et al. (2007) Ectopic expression of myostatin induces atrophy of adult skeletal muscle by decreasing muscle gene expression. Endocrinology 148: 3140-3147.
3. Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LA, et al. (2002) Functional improvement of dystrophic muscle by myostatin blockade. Nature 420: 418-421.
4. McPherron AC, Lawler AM, Lee SJ (1997) Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387: 83-90.
5. Nakatani M, Takehara Y, Sugino H, Matsumoto M, Hashimoto O, et al. (2008) Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice. Faseb J 22: 477-487.
6. Whittemore LA, Song K, Li X, Aghajanian J, Davies M, et al. (2003) Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem Biophys Res Commun 300: 965-971.
7. Wagner KR, Liu X, Chang X, Allen RE (2005) Muscle regeneration in the prolonged absence of myostatin. Proc Natl Acad Sci U S A 102: 2519-2524.
8. Li ZB, Kollias HD, Wagner KR (2008) Myostatin directly regulates skeletal muscle fibrosis. J Biol Chem 283: 19371-19378.
9. Bogdanovich S, McNally EM, Khurana TS (2007) Myostatin blockade improves function but not histopathology in a murine model of limb-girdle muscular dystrophy 2C. Muscle Nerve 37: 308-316.
10. Li ZF, Shelton GD, Engvall E (2005) Elimination of myostatin does not combat muscular dystrophy in dy mice but increases postnatal lethality. Am J Pathol 166: 491-497.
11. Parsons SA, Millay DP, Sargent MA, McNally EM, Molkentin JD (2006) Age-dependent effect of myostatin blockade on disease severity in a murine model of limb-girdle muscular dystrophy. Am J Pathol 168: 1975-1985.
12. Barton ER, Morris L, Musaro A, Rosenthal N, Sweeney HL (2002) Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J Cell Biol 157: 137-148.
13. Bogdanovich S, Perkins KJ, Krag TO, Whittemore LA, Khurana TS (2005) Myostatin propeptide-mediated amelioration of dystrophic pathophysiology. Faseb J 19: 543-549.
14. Qiao C, Li J, Jiang J, Zhu X, Wang B, et al. (2008) Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice. Hum Gene Ther 19: 241-254.
15. Haidet AM, Rizo L, Handy C, Umapathi P, Eagle A, et al. (2008) Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors. Proc Natl Acad Sci U S A 105: 4318-4322.
16. Hill JJ, Davies MV, Pearson AA, Wang JH, Hewick RM, et al. (2002) The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem 277: 40735-40741.
17. Hill JJ, Qiu Y, Hewick RM, Wolfman NM (2003) Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains. Mol Endocrinol 17: 1144-1154.
18. Lee SJ, McPherron AC (2001) Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci U S A 98: 9306-9311.
19. Tsuchida K, Arai KY, Kuramoto Y, Yamakawa N, Hasegawa Y, et al. (2000) Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-beta family. J Biol Chem 275: 40788-40796.
20. Bartoli M, Poupiot J, Vulin A, Fougerousse F, Arandel L, et al. (2007) AAV-mediated delivery of a mutated myostatin propeptide ameliorates calpain 3 but not alpha-sarcoglycan deficiency. Gene Ther 14: 733-740.
21. Pacak CA, Conlon T, Mah CS, Byrne BJ (2008) Relative persistence of AAV serotype 1 vector genomes in dystrophic muscle. Genet Vaccines Ther 6: 14.
22. Gao GP, Alvira MR, Wang L, Calcedo R, Johnston J, et al. (2002) Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci U S A 99: 11854-11859.
23. Wang Z, Zhu T, Qiao C, Zhou L, Wang B, et al. (2005) Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat Biotechnol 23: 321-328.
24. Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panettieri RA, et al. (1991) The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352: 536-539.
25. Yang W, Zhang Y, Li Y, Wu Z, Zhu D (2007) Myostatin induces cyclin D1 degradation to cause cell cycle arrest through a phosphatidylinositol 3-kinase/ AKT/GSK-3 beta pathway and is antagonized by insulin-like growth factor 1. J Biol Chem 282: 3799-3808.
26. Quinlan JG, Hahn HS, Wong BL, Lorenz JN, Wenisch AS, et al. (2004) Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings. Neuromuscul Disord 14: 491-496.
27. Bostick B, Yue Y, Long C, Duan D (2008) Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin/utrophin expression. Circ Res 102: 121-130.
28. Wagner KR, McPherron AC, Winik N, Lee SJ (2002) Loss of myostatin attenuates severity of muscular dystrophy in mdx mice. Ann Neurol 52: 832-836.
29. Grobet L, Pirottin D, Farnir F, Poncelet D, Royo LJ, et al. (2003) Modulating skeletal muscle mass by postnatal, muscle-specific inactivation of the myostatin gene. Genesis 35: 227-238.
30. Welle S, Bhatt K, Pinkert CA, Tawil R, Thornton CA (2007) Muscle growth after postdevelopmental myostatin gene knockout. Am J Physiol Endocrinol Metab 292: E985-991.
31. Yang J, Ratovitski T, Brady JP, Solomon MB, Wells KD, et al. (2001) Expression of myostatin pro domain results in muscular transgenic mice. Mol Reprod Dev 60: 351-361.
32. Girgenrath S, Song K, Whittemore LA (2005) Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow- and fast-type skeletal muscle. Muscle Nerve 31: 34-40.
33. Anderson JE, Bressler BH, Ovalle WK (1988) Functional regeneration in the hindlimb skeletal muscle of the mdx mouse. J Muscle Res Cell Motil 9: 499-515.
34. Earnshaw JC, Kyprianou P, Krishan K, Dhoot GK (2002) Differentiation of original and regenerated skeletal muscle fibres in mdx dystrophic muscles. Histochem Cell Biol 118: 19-27.
35. Marshall PA, Williams PE, Goldspink G (1989) Accumulation of collagen and altered fiber-type ratios as indicators of abnormal muscle gene expression in the mdx dystrophic mouse. Muscle Nerve 12: 528-537.
36. Huang Z, Chen D, Zhang K, Yu B, Chen X, et al. (2007) Regulation of myostatin signaling by c-Jun N-terminal kinase in C2C12 cells. Cell Signal 19: 2286-2295.
37. Philip B, Lu Z, Gao Y (2005) Regulation of GDF-8 signaling by the p38 MAPK. Cell Signal 17: 365-375.
38. Yang W, Chen Y, Zhang Y, Wang X, Yang N, et al. (2006) Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression. Cancer Res 66: 1320-1326.
39. Morissette MR, Cook SA, Buranasombati C, Rosenberg MA, Rosenzweig A (2009) Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt. Am J Physiol Cell Physiol 297: C1124-1132.
40. Forbes D, Jackman M, Bishop A, Thomas M, Kambadur R, et al. (2006) Myostatin auto-regulates its expression by feedback loop through Smad7 dependent mechanism. J Cell Physiol 206: 264-272.
41. Amthor H, Macharia R, Navarrete R, Schuelke M, Brown SC, et al. (2007) Lack of myostatin results in excessive muscle growth but impaired force generation. Proc Natl Acad Sci U S A 104: 1835-1840.
42. Mendias CL, Marcin JE, Calerdon DR, Faulkner JA (2006) Contractile properties of EDL and soleus muscles of myostatin-deficient mice. J Appl Physiol 101: 898-905.
43. Larsson L, Moss RL (1993) Maximum velocity of shortening in relation to myosin isoform composition in single fibres from human skeletal muscles. J Physiol 472: 595-614.
44. Smerdu V, Karsch-Mizrachi I, Campione M, Leinwand L, Schiaffino S (1994) Type IIx myosin heavy chain transcripts are expressed in type IIb fibers of human skeletal muscle. Am J Physiol 267: C1723-1728.
45. Salerno MS, Thomas M, Forbes D, Watson T, Kambadur R, et al. (2004) Molecular analysis of fiber type-specific expression of murine myostatin promoter. Am J Physiol Cell Physiol 287: C1031-1040.
46. Nigro G, Comi LI, Politano L, Bain RJ (1990) The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 26: 271-277.
47. Artaza JN, Reisz-Porszasz S, Dow JS, Kloner RA, Tsao J, et al. (2007) Alterations in myostatin expression are associated with changes in cardiac left ventricular mass but not ejection fraction in the mouse. J Endocrinol 194: 63-76.
48. Cohn RD, Liang HY, Shetty R, Abraham T, Wagner KR (2007) Myostatin does not regulate cardiac hypertrophy or fibrosis. Neuromuscul Disord 17: 290-296.
49. Spurney CF, Knoblach S, Pistilli EE, Nagaraju K, Martin GR, et al. (2008) Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart. Neuromuscul Disord 18: 371-381.
50. Van Erp C, Irwin NG, Hoey AJ (2006) Long-term administration of pirfenidone improves cardiac function in mdx mice. Muscle Nerve 34: 327-334.
51. Sharma M, Kambadur R, Matthews KG, Somers WG, Devlin GP, et al. (1999) Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct. J Cell Physiol 180: 1-9.
52. Shyu KG, Lu MJ, Wang BW, Sun HY, Chang H (2006) Myostatin expression in ventricular myocardium in a rat model of volume-overload heart failure. Eur J Clin Invest 36: 713-719.
53. Wagner KR, Fleckenstein JL, Amato AA, Barohn RJ, Bushby K, et al. (2008) A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol 63: 561-571.
54. Mingozzi F, Hasbrouck NC, Basner-Tschakarjan E, Edmonson SA, Hui DJ, et al. (2007) Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver. Blood 110: 2334-2341.
55. Garg RR, Bally-Cuif L, Lee SE, Gong Z, Ni X, et al. (1999) Cloning of zebrafish activin type IIB receptor (ActRIIB) cDNA and mRNA expression of ActRIIB in embryos and adult tissues. Mol Cell Endocrinol 153: 169-181.
56. Cooper BJ, Winand NJ, Stedman H, Valentine BA, Hoffman EP, et al. (1988) The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature 334: 154-156.
57. Harding TC, Koprivnikar KE, Tu GH, Zayek N, Lew S, et al. (2004) Intravenous administration of an AAV-2 vector for the expression of factor IX in mice and a dog model of hemophilia B. Gene Ther 11: 204-213.
58. Shimatsu Y, Katagiri K, Furuta T, Nakura M, Tanioka Y, et al. (2003) Canine X-linked muscular dystrophy in Japan (CXMDJ). Exp Anim 52: 93-97.
59. Shimatsu Y, Yoshimura M, Yuasa K, Urasawa N, Tomohiro M, et al. (2005) Major clinical and histopathological characteristics of canine X-linked muscular dystrophy in Japan, CXMDJ. Acta Myol 24: 145-154.
60. Bish LT, Morine K, Sleeper MM, Sanmiguel J, Wu D, et al. (2008) AAV9 Provides Global Cardiac Gene Transfer Superior to AAV1, AAV6, AAV7, and AAV8 in the Mouse and Rat. Hum Gene Ther.
61. Barton ER (2006) Impact of sarcoglycan complex on mechanical signal transduction in murine skeletal muscle. Am J Physiol Cell Physiol 290: C411-419.
62. Silcocks PB, Munro JF, Steeds RP, Channer KS (1997) Prognostic implications of qualitative assessment of left ventricular function compared to simple routine quantitative echocardiography. Heart 78: 237-242.